Austrian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Risk of Cardiovascular Events in Eligible Patients -- -- Effective 1 April 2025, Austrian ...

Colorectal cancer, the second most common cause of cancer-related death, is mainly treated with chemotherapy, but its ...

Colorectal cancer, the second most common cause of cancer-related death, affects almost 2 million people worldwide every year.

Cholesterol levels are related to heart health, but how much do we really know about its impact on our overall health? Dive ...

It wasn’t until late last year, 35 years into its history, that Ionis Pharmaceuticals e | To support the launch of Tryngolza, ...

Diet on Weight Loss and Cardiovascular Disease Risk Factors in Overweight and/or Obesity: A Systematic Review and ...

Researchers from Osaka University find that tricaprin improves survival in patients with a novel heart disease, triglyceride ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

Director of the Bahawalpur Institute of Nuclear Medicine and Oncology (BINO) Dr Iftikhar Aalam stated on Wednesday that 80 per cent ...

FCS has no approved treatments in the US ... in which olezarsen was shown to reduce triglycerides by 49% after six months in patients with HTG and high cardiovascular risk when added to standard ...